|
| |
Iodide in high dosage acutely decreases the release of thyroid hormone from the gland, apparently
by inhibition of proteolysis, with a more marked effect in thyrotoxicosis than in the normal gland.
Glucocorticoids exert a similar effect that was initially attributed to TSH suppression, but the
effect also occurs when TSH is suppressed, as in Graves' disease. Lithium chronically inhibits
thyroid hormone release as a result of an apparent decrease in proteolysis of thyroglobulin (Lazarus,
1996). These agents are occasionally used as additional medications in the management of
complicated thyrotoxicosis.
Table 1: Principal medications that influence thyroid hormone or TSH levels
|
|
+ increase - decrease
|
| Modify pituitary TSH secretion |
|
|
Dopamine, dobutamine, glucocorticoids, octreotide
|
- |
| Affect thyroid hormone synthesis and release by delivering iodine load |
|
|
Contrast agents, amiodarone, topical preparations
|
+/- |
| Influence thyroid hormone synthesis or release |
|
|
Lithium, glucocorticoids, aminiglutethimide?
|
- |
| Inhibit T4-T3 5' Deiodination |
|
|
Amiodarone, glucocorticoids, beta blockers*
Contrast agents, e.g. iopanoic acid, ipodate
|
- |
| Modify immune function |
|
|
Interleukin 1, interferon α, interferon β
Monoclonal antibody therapy
|
see text
see text |
| Modify binding of T4 and T3 to plasma proteins |
|
|
a. Alter concentration of T4 binding globulin
Estrogen, heroin, methadone
Clofibrate, 5-fluouracil, perphenazine, tamoxifen
b. Displace T4 and T3 from binding proteins
Furosemide, salicylates, phenytoin, carbamazepine
Non-steroidal antiinflammatory agents #
Heparin Y
|
+ +
- - - |
| Displace T4 from tissue pool |
|
|
Alkylating agents, oral cholecystographic agents
|
+ |
| Modify thyroid hormone action |
|
|
Amiodarone, phenytoin?
|
+/- |
| Increase clearance of T4,T3 |
|
|
Barbiturates, phenytoin, carbamazepine
Rifampicin
Sertraline?, fluoxetine?, dothiepin?
|
+ + + |
| Impair absorption of ingested T4 |
|
|
Aluminium hydroxide, ferrous sulfate, cholestyramine
Colestipol, sucralfate, soya preparations
Kayexalate
|
- - |
+ : Stimulatory; - : inhibitory; +/- effect depends on thyroid status
* Those with membrane-stabilizing effect, e.g. propranolol Y In vitro effect
of in vivo heparin administration (see figure)
# Some members of the group (see Lim et al, 1988)
Table 2: Medications with multiple effects on the pituitary-thyroid axis
| Glucocorticoids |
Inhibit TSH secretion
Impair thyroid hormone release from the gland
Inhibit 5' deiodination of T4 and rT3
Decrease concentration of TBG
|
| Amiodarone |
Delivers iodine load
Iodine-induced thyrotoxicosis (Jod-Basedow)
Iodine-induced hypothyroidism
Causes unique form of thyrotoxicosis due to thyroiditis
Retards T4 clearance
Inhibits 5' deiodination of T4 and rT3
Thyroid hormone receptor antagonist?
Augments TSH secretion
|
| Phenytoin |
Inhibits T4 and T3 binding to TBG
Accelerates T4 clearance and metabolism
Thyroid hormone receptor action ?
|
|
|